New shot could tame stubborn high cholesterol
NCT ID NCT06471218
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tested a new medicine called SHR-1918, given as multiple shots under the skin, in 44 adults with high cholesterol that was not well controlled by current treatments. The goal was to see if it safely lowers 'bad' LDL cholesterol over 24 weeks. This is a phase 2 trial, meaning it's an early step to check if the drug works and is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Meizhou People's Hospital
Meizhou, Guangdong, 514031, China
Conditions
Explore the condition pages connected to this study.